We are live on
!
Find out more
BLAM
Bourne Lent Asset Management Portfolio holdings
AUM
$272M
1-Year Est. Return
30.95%
This Fund
S&P 500
This Quarter
Est. Return
+3.03%
1 Year Est. Return
+30.95%
3 Year Est. Return
+75.66%
5 Year Est. Return
+99.24%
10 Year Est. Return
+591.34%
AUM
$248M
AUM Growth
+$1.58M
(+0.64%)
Cap. Flow
+$579K
Cap. Flow
% of AUM
0.23%
Top 10 Holdings %
Top 10 Hldgs %
73.44%
Holding
64
New
4
Increased
10
Reduced
10
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pacific Biosciences
PACB
|
+$364K |
| 2 |
IBM
IBM
|
+$210K |
| 3 |
Automatic Data Processing
ADP
|
+$208K |
| 4 |
Emcor
EME
|
+$198K |
| 5 |
Caterpillar
CAT
|
+$198K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVTA
Invitae Corporation
NVTA
|
+$360K |
| 2 |
Bristol-Myers Squibb
BMY
|
+$291K |
| 3 |
Pfizer
PFE
|
+$111K |
| 4 |
Booking.com
BKNG
|
+$107K |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$26.4K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 44.62% |
| 2 | Healthcare | 22.29% |
| 3 | Communication Services | 15.01% |
| 4 | Industrials | 7.44% |
| 5 | Consumer Discretionary | 3.89% |
Similar funds
SC
SC
AGP
SFPG
TP
S
SS
LAM
Bourne Lent Asset Management's Q1 2024 Portfolio in Review
As of Q1 2024, Bourne Lent Asset Management held 64 positions worth $248M, up 0.64% from $246M the previous quarter. Its ten largest holdings account for 73% of the portfolio.
Bourne Lent Asset Management's Q1 2024 filing shows 4 new, 10 increased, 10 reduced and 1 closed positions. Its largest new stake was IBM: 1,150 shares worth $220K. The largest sale was Invitae Corporation, an estimated $360K.
By sector, the portfolio is most concentrated in Technology at 45% of assets, down from 46% a quarter earlier, followed by Healthcare and Communication Services.
- Bourne Lent Asset Management's largest Q1 2024 buy was IBM: 1,150 shares worth $220K.
- Bourne Lent Asset Management added most to Pacific Biosciences in Q1 2024, an estimated $364K increase.
- Bourne Lent Asset Management's biggest Q1 2024 reduction was Bristol-Myers Squibb, cutting an estimated $291K.
- Bourne Lent Asset Management fully exited Invitae Corporation in Q1 2024, selling an estimated $360K.
- Bourne Lent Asset Management's ten largest holdings make up 73% of its $248M portfolio in Q1 2024.
- Bourne Lent Asset Management opened 4 new positions and closed 1 in Q1 2024.
- Bourne Lent Asset Management's portfolio value rose 0.64% quarter-over-quarter to $248M.
Based on Bourne Lent Asset Management's 13F filing for Q1 2024, filed 12 Apr 2024.